| Treatment of HER2-positive metastatic breast cancer with lapatinib and capecitabine in the lapatinib expanded access programme, including efficacy in brain metastases–the UK … S Sutherland, S Ashley, D Miles, S Chan, A Wardley, N Davidson, R Bhatti, ... British journal of cancer 102 (6), 995-1002, 2010 | 168 | 2010 |
| Human apurinic/apyrimidinic endonuclease (APE1) is a prognostic factor in ovarian, gastro-oesophageal and pancreatico-biliary cancers A Al-Attar, L Gossage, KR Fareed, M Shehata, M Mohammed, AM Zaitoun, ... British journal of cancer 102 (4), 704-709, 2010 | 104 | 2010 |
| Calpain‐1 expression is associated with relapse‐free survival in breast cancer patients treated with trastuzumab following adjuvant chemotherapy SJ Storr, CM Woolston, FFT Barros, AR Green, M Shehata, SY Chan, ... International Journal of Cancer 129 (7), 1773-1780, 2011 | 48 | 2011 |
| Lapatinib: a tyrosine kinase inhibitor with a clinical role in breast cancer A Mukherjee, AS Dhadda, M Shehata, S Chan Expert Opinion on Pharmacotherapy 8 (13), 2189-2204, 2007 | 46 | 2007 |
| Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy CM Woolston, S Deen, A Al-Attar, M Shehata, SY Chan, SG Martin Free Radical Biology and Medicine 49 (8), 1263-1272, 2010 | 44 | 2010 |
| Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer HA Alagizy, MA Shehata, TA Hashem, KK Abdelaziz, MM Swiha Hematology/Oncology and Stem Cell Therapy 8 (1), 22-27, 2015 | 42 | 2015 |
| Human leukocyte antigen class I expression is an independent prognostic factor in advanced ovarian cancer resistant to first-line platinum chemotherapy M Shehata, A Mukherjee, S Deen, A Al-Attar, LG Durrant, S Chan British journal of cancer 101 (8), 1321-1328, 2009 | 40 | 2009 |
| Topo2α protein expression predicts response to anthracycline combination neo-adjuvant chemotherapy in locally advanced primary breast cancer A Mukherjee, M Shehata, P Moseley, E Rakha, I Ellis, S Chan British journal of cancer 103 (12), 1794-1800, 2010 | 36 | 2010 |
| CD14+ HLA‐DR low/− monocytes as indicator of disease aggressiveness in B‐cell non‐Hodgkin lymphoma KA Khalifa, HM Badawy, WM Radwan, MA Shehata, MA Bassuoni International Journal of Laboratory Hematology 36 (6), 650-655, 2014 | 33 | 2014 |
| The prognostic and predictive power of redox protein expression for anthracycline-based chemotherapy response in locally advanced breast cancer CM Woolston, L Zhang, SJ Storr, A Al-Attar, M Shehata, IO Ellis, SY Chan, ... Modern Pathology 25 (8), 1106-1116, 2012 | 32 | 2012 |
| T cell density and location can influence the prognosis of ovarian cancer A Al-Attar, M Shehata, L Durrant, P Moseley, S Deen, S Chan Pathology & Oncology Research 16, 361-370, 2010 | 18 | 2010 |
| The first BGICC consensus and recommendations for breast cancer awareness, early detection and risk reduction in low‐and middle‐income countries and the MENA region H Elghazaly, AT Aref, BO Anderson, B Arun, CH Yip, H Abdelaziz, ... International journal of cancer 149 (3), 505-513, 2021 | 14 | 2021 |
| Breast-gynaecological & immuno-oncology international cancer conference (BGICC) consensus and recommendations for the management of triple-negative breast cancer H Elghazaly, HS Rugo, HA Azim, SM Swain, B Arun, M Aapro, EA Perez, ... Cancers 13 (9), 2262, 2021 | 11 | 2021 |
| Relationship of CK8/18 expression pattern to breast cancer immunohistochemical subtyping in Egyptian patients HA Aiad, RM Samaka, NY Asaad, MA Kandil, MA Shehata, IM Miligy ecancermedicalscience 8, 2014 | 9 | 2014 |
| Liposomal doxorubicin in breast cancer M Shehata, A Mukherjee, R Sharma, S Chan Women’s Health 3 (5), 557-569, 2007 | 7 | 2007 |
| Early expression of urinary neutrophil gelatinase-associated lipocalin biomarker predicts acute kidney injury complicating circulatory shock M Fouda, HM Sherif, M Shehata, A Ibrahim The Egyptian Journal of Critical Care Medicine 1 (2), 79-86, 2013 | 6 | 2013 |
| Clinical recommendations in the management of advanced prostate cancer: International Gastrointestinal, Liver and Uro-oncology (IGILUC 2019) experts. EEDM Elghazaly H, Mottet N, Garcia J, Oudard S, Roach M, Abbou C ... World J Urol, 2020 | 3* | 2020 |
| Overexpression of carbonic anhydrase IX is a dismal prognostic marker in breast carcinoma in Egyptian patients RM Samaka, MM Abd El-Wahed, DR Al Sharaky, MA Shehata, ... Applied Immunohistochemistry & Molecular Morphology 24 (6), 405-413, 2016 | 3 | 2016 |
| Paclitaxel as continuation maintenance therapy in patients with advanced non-small cell lung cancer SF Gohar, K Abd El Aziz, N Abd El Bary, M Shehata, S Alhassanin, ... Annals of Oncology 30, ix172, 2019 | 1 | 2019 |
| Carbonic anhydrase IX expression and localization in breast carcinoma RM Samaka, MM Abd El-Waheda, DR Al Sharaky, MA Aleskandarany, ... Menoufia Medical Journal 28 (3), 693, 2015 | 1 | 2015 |
